KDM1A Identified as a Potential Oncogenic Driver and Prognostic Biomarker via Multi-Omics Analysis

Figure 4

Analysis of phosphorylation levels of KDM1A in different cancers based on the CPTAC data set via the UALCAN. (a) Schematic diagram showed the phosphoprotein sites of KDM1A (NP_001350583.1) that were expressed at different levels in tumors compared with normal tissues. (b) and (c) Phosphorylation analysis of KDM1A protein in breast cancer and clear cell RCC, respectively.

(a)

(b)

(c)